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DISCUSSION: BACTERIAL AGENTS
DR. KILBURN: If I have heard correctly, Doctors Gareth Green and Sanford
have drawn opposite conclusions. Although patients seem to have bronchitis and/or
emphysema, they often die of bacterial overgrowth of the lung which has been called
gram-negative pneumonia. This may have to be looked at as a highly important dis-
ease because it causes death, although it is not the original disease. Dr. Green's work
suggests the latter is true, but Dr. Sanford has concluded that a bacterial etiology
isn't important. I interpret this to mean that bacteria do not cause either emphysema
or bronchitis. Perhaps both speakers would clarify their positions.
DR. GARETH GREEN: There isn't as much disagreement as might appear. I
have been talking about what happens to the host under a variety of circumstances.
Bacterial infection may be but one of these circumstances. At any step along the road
to chronic lung disease, acute bacterial infection can occur. In the patient who has a
gram-negative infection as the final episode, frequently following infection with a
succession of bacterial species, the lung exists in a host with essentially no host de-
fense remaining. However, the bacterial infection, although lethal and therefore im-
portant, is hardly primary.
DR. SANFORD: I think Dr. Green and I are in virtually complete agreement. I
would like to clarify any confusion which may have been caused by Dr. Kilburn's
remarks. From the available data, and under the circumstances wherein they have
been evaluated, it is fair to say that bacteria do not appear to be the initiating primary
etiology of either chronic bronchitis or emphysema. However, it is entirely feasible
to design an experiment and to test the hypothesis, in an animal model, that bacteria
might produce the same sequence of changes as caused by a variety of noninfectious
noxious agents. This is not to say that bacteria may not play a very major secondary
role once other factors have initiated chronic bronchitis or the destruction of various
alveolar defense mechanisms. The pathogenesis of obstructive lung disease is clearly
multifactorial in progression if not in primary etiology; yet most of us have been
monofactorial in our experimental approaches to it.
DR. RENZETTI: I wonder if Dr. Sanford has found any evidence in the literature
that the rat might develop spontaneous emphysema, and if this apparently spontaneous
bronchiectasis might not create some trouble in using that animal for the determina-
tion of bronchitis/emphysema?
DR. SANFORD: Spontaneous emphysema or bronciectasis is known to be a prob-
lem especially in older rats. I was rather disturbed to learn that Dr. Green had ob-
served bronciectasis in three-month-old rats.
DR. GREEN: In many published reports, where histologic sections are shown, it
is quite clear there is other coincident chronic lung disease. It is possible to eliminate
this background disease. Most animal species have these problems. The disease ap-
pears to be a congenitally acquired infectious process, in itself a very interesting model,
which can be bred out of the animals by Cesarean derivation and isolation.
DR. SAFFIOTTI: I would like to support the point of view that Dr. Green has
expressed. One may control bacterial contamination by using either germ-free animals
or specific pathogen-free animals, which lend themselves to studying the effect of
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selected bacterial contaminants. I think this would be particularly important when
evaluating combined effects of different treatments. such as silica or other agents. The
effects of such agents have been observed always in the presence of bacterial con-
tamination. We really do not know how much host response is due to the agent itself
and how much is due to the combined action of bacterial contamination and other in-
flammatory mechanisms. Thus, it is important to stress the need for "clean" animal
systems. The rat is probably as good as any other animal if the bacterial contamina-
tion is controlled.
DR. FREEMAN: I would agree with Dr. Saffiotti. In our experience, rats have
varied a good deal, depending upon their source. There is nothing worse about the
rat than any other species. The important factor is adequate control. If the controls
aren't good, neither is the rest of the experiment.
DR. H. V. THOMAS: I wonder whether Drs. Green or Sanford have given any
thought to the possibility that protein alteration may well precede the bactericidal
effect as a consequence of phagocytic action in the lung? It has been noted that the
bactericidal mechanism is aggravated by certain conditions-namely, starvation, ne-
phrosis, old age-conditions which bring about a decrease in protein synthesis. In
addition, the administration of tryptophan and papain causes changes in lung tissue
which stimulate lung disease.
Dr. GREEN: We don't really know the reasons for the change in macrophage
function. Up to this point, we have simply described changes that occur under a
variety of circumstances. It may be protein synthesis under certain circumstances,
while in others it may be enzymatic alterations or changes in pH. It could be a great
variety of mechanisms. We just don't know the detailed cellular effect.
DR. HARFORD: Dr. Green's experiments with radioactive bacteria have raised
a question in my mind concerning the function of mucus in ciliary action. A number
of years ago we stained the broncial epithelium of the mouse and found no mucous
cells. I wonder whether the cilia of mouse bronchi without a mucous blanket work
effectively in removing particles. Perhaps Dr. Green's contention that ciliary action
has a minor role in clearing bacteria from the mouse lung might reflect the absence
of mucus.
DR. GREEN: We can cite some experiments which show that the larger radio-
active particles are more readily removed than the smaller ones. Also, in the rat
there is absolutely no removal of radioactivity during this same time interval. We
have presumed this was because the greater proportion of particles are deposited distal
to the muco-ciliary stream in the rat. To the best of my knowledge, there is muco-ciliary
streaming in the rat. Not having measured muco-ciliary transport at the bronchiolar
level of the mouse lung, I couldn't really say whether it requires visible mucous glands
or not.
DR. KILBURN: I think Dr. Harford put his finger on a question that has
troubled Dr. Gross and me; how are materials cleared from airways distal to those
with mucosal goblet cells? The highly secretory Clara cells, which resemble gastric
parietal cells and are found in terminal and respiratory bronchioles, probably provide
a thin fluid layer which is transported by cilia. The clearance rate from these airways
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is thought to be much slower-hours rather than minutes-than in the trachea. The
related question is, how are particles moved from the air spaces or respiratory air-
ways to the muco-ciliary transport system? The mouse lung may be a good model
in which to study clearance distal to terminal bronchioles. The terminal bronchiole
is the locus of many diseases; certainly it is the point at which one lesion could inter-
fere with clearance and respirtory function of an entire pneumon. Thus, I have no
evidence to controvert Dr. Harford's observations that mucus is not produced beyond
extrapulmonary bronchi in the mouse. However, fluid streaming by other forces, e.g.,
the surface tension-dependent physical filming, is a possible mechanism for clearing
both distal zones. Such clearance is much slower than muco-ciliary transport in the
frog model. No one has observed this process or the interface of transport in the
mammalian lung. C. C. Macklin, Paul Gross, and Carl Harford are among the few
who have been concerned with this problem in recent times.
DR. GREEN: I don't want to leave the impression that the radioactivity is not
removed from the alveoli. If these animals are followed for 24 or 48 hours, the same
kind of clearance curve occurs as reported in a variety of radioactive studies. There
is removal, but its time course is much longer then the bactericidal event. What we
are talking about is a very much earlier function, one which happens in the first few
hours rather than after 24 or 48 hours.
DR. BOREN: I would like to comment on the word "clearance." I think there is
a lot of confusion here. When used in the context of our discussion the word means
getting something out of the lung. Most of Dr. Green's studies were on a decreasing
ability to grow bacteria; this is not clearance. What I was proposing this morning
was the transport of particles hitting the alveolar wall to phagocytic cells in the al-
veolar wall. Doctor Green observed the same rates for staphylococci and proteus, which
suggests to me that there must be transport of the particles at the same rate to the
phagocytizing cells. "Clearance" is such a general term that it does not specify exactly
what we mean. We have to think of transport in reference to the level we are con-
sidering. I believe you were talking about the transport of bacteria to phagocytizing
cells which doesn't have anything to do with muco-ciliary function.
DR. LANDY: My comments are addressed to Dr. Green with regard to what I
suspect is an oversimplified version of a model. I would like to have him address him-
self to the role of opsinizing factors for the bacterial cells being taken up by macro-
phages, i.e., removal by these cells at the beginning of the process. I can easily visualize
that in some instances, the result might be death of the phagocytic cell as well as
changes in the bacterium. There might also be some useful comments at this moment
about the newly emerging recognition of the role of secretory immunoglobulins-that
is, the gamma A-and their relevance to this over-all process. I find it difficult to be-
lieve that these bacteria are initially palatable to these cells unless they are first pre-
pared, not necessarily by immune factors but rather by immunoglobulins present in
the normal non-immunized individual. This is, after all, the situation we are concerned
with almost exclusively.
DR. GREEN: That is a very pertinent comment and question. I have no doubt that
opsinizing factors are involved and that many factors related to phagocytosis are
involved-the metabolic state of the cell, the particular physico-chemical milieu at the
time of phagocytosis, the presence of opsonins, etc. We have measured the final result
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of many factors, the final result being phagocytosis. One can impinge on this event at
many different levels. This is also true in terms of survival of bacteria within the
macrophage. There is no doubt that there are bacteria which will survive within the
macrophage. There is no doubt that there are primary pathogens for the lung that,
regardless of the state of the host, will still be pathogenic. However, what we are
concerned with is the measurement of cell function as determined by a successful
phagocytic event.
DR. LANDY: May I ask a final point of clarification which may be dealt with
more directly by Dr. Myrvik since this particular experiment may already have been
carried out by him.
I would be interested in knowing what alveolar macrophages do with these bacteria
in an in zitro situation where the investigator can exercise better control of the ex-
perimental conditions. Most of the information I am familiar with has been obtained
with peritoneal macrophages, where in titro killing of the bacterial types following
opsinization is a very efficient process.
DR. MYRVIK: The alveolar macrophages in our experience have the same re-
quirement for opsonins as do peritoneal macrophages. Listeria monocytogenes and cer-
tain species of mycobacteria can be phagocytized in vitro in the absence of opsonins,
whereas gram-negative microorganisms are not ingested by alveolar macrophages
unless opsonins are present.
DR. FORSYTH: Mice harbor a number of latent viruses and mycoplasmas which
will be discussed in detail elsewhere. In interpreting the experimental data, the pos-
sibility that the effect produced was caused by the activation of a latent or indigenous
agent must be considered. The only way to avoid this is by very careful monitoring
of the animals for these agents.
I would like to direct a question to Dr. Austrian. Do you have any additional in-
formation on the role of anaerobic bacteria in chronic pulmonary disease?
DR. AUSTRIAN: Unfortunately, in many instances, the technical difficulties in
studying anaerobic bacteria have discouraged their intensive study. Perhaps Dr.
Braude, who has been interested in these organisms in recent years, would have some
additional comments. I would like to comment that using aerosols in experimental
models may not always be representative of what goes on in the genesis of acute in-
fection in man. The fact that bronchial embolization plays an important role in the
genesis of pneumonias, and that other physical factors enter into the situation should
not be overlooked in the study of these pathogenic phenomena.
DR. BRAUDE: I did a systematic study of the anaerobic organisms in chronic
bronchopulmonary disease. There is no question about the pathogenicity of anaerobes
in the lung, as they can produce actinomycosis, lung abscess and empyema. We have
even isolated anaerobic streptococci in pure culture from lung biopsies in chronic
interstitial penumonitis. The pooling of secretions that occurs in chronic broncho-
pumonary disease provides a very good place for anaerobes to proliferate. Charles
Hefflin and I studied a large series of these cases, and found most of them to have
large numbers of anaerobes in their sputa. The collection of secretions without con-
tamination by mouth bacteria was technically difficult. We tried to get around this by
painting the throat with Serratia marcescens and having the patient wash out the
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mouth with national formulary mouthwash containing 26 per cent alcohol. We ac-
cepted only those specimens that were negative for S. marcescens. While this pro-
cedure has been frowned upon because S. marcescens can be pathogenic in the lung,
we encountered no such problem. We isolated Bacteroides fragilis, B. funduliformis,
anaerobic streptococci, Veillonella spp. and Actinomyces spp. from the majority of
the patients. Bacteroides fragilis was the most frequently isolated bacterium, a finding
of some interest because B. fragilis is resistant to tetracycline clinically and in the test
tube. In a number of studies tetracycline has controlled some of the purulence in
chronic bronchopulmonary disease to a degree not duplicated by penicillin. Since B.
fragilis is sensitive to tetracycline and resistant to penicillin, the observation on the
prominence of bacteroides would fit with the clinical response of some cases to tetra-
cycline. I think the studies indicate that more work should be done on the anaerobes,
but I won't be happy with the results until transtracheal aspiration is done in a large
series of cases.
DR. GREEN: I feel I should make a comment on Dr. Forsyth's comment about
other agents as possible mediators complicating the effect of the virus. This is a very
important problem not only for studies in virus infections but for almost any situation
in the study of animal models. We have spent about five years studying murine virus
infections and trying to sort out which effects are due to viruses that are administered
and which are due to viruses already in the lung.
We have been limited by the technical ability to identify all viruses that are in the
lung. In experiments in which we can identify murine viruses we get different effects
from those in which we can't identify murine viruses. These differences give rise to
speculation that no other complicating viruses are present. It is a big problem, but I
think the viral effect is real and not due to mycoplasma or adventitious viruses.
There certainly are other modes of infection in the lung, not only by endobronchial
plugging, but also by intravascular emboli. These mechanisms don't necessarily need
to exclude functional changes in the alveolar macrophage. If one considers what hap-
pens distal to a bronchial occlusion by mucus, we know that gas tensions change;
carbon dioxide may build up and oxygen may decrease in the locus. If we test the
whole system, we can depress macrophage activity by reductions in PO2. Therefore,
we may be dealing with a common mechanism whether infection be initiated by bron-
chial occlusion or by aerosol.
DR. TYLER: A spontaneous model of emphysema is seen in horses. The term
"heaves" is a very confusing one. "Heaves" is a clinical sign attributed to two or more
specific disease entities, namely, bronchitis/bronchiolitis, and chronic pulmonary em-
physema. We have seen chronic pulmonary emphysema in wild horses directly off the
Nevada range. Thus, the idea of hypersensitivity to moldy stabled hay doesn't seem
to hold.
There is a great difference in the way horses are handled in the East and in the
West; this may account for some of the disagreement in the literature. We have seen
emphysematous horses with essentially no bronchiolitis. Doctor H. Gerber has reported
similar observations on horses in Switzerland.
DR. HAYDON: I would like to comment on bacterial infections in N02-treated
animals. The rats I have worked with lived a very long time without bacterial infec-
tions. The NO0-exposed rats die without histological evidence of bacterial infection.
However, the rabbit seems to develop bacterial infections. Here I believe the most
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important factors are the environmental circumstances occurring during the exposure,
and the effects of the necessary procedure for the physiological studies. These results
I feel demonstrate that bacterial infections are not necessary for the development of ex-
perimental emphysema, but they may occur with it.
DR. MYRVIK: I would like to comment that the motility of macrophages is prob-
ably linked to their level of hexose monophosphate shunt (HMS) metabolism. If one
feeds carbon particles to alveolar macrophages in vitro, little or no influence on HMS
activity is observed. However, if one feeds the same mass of killed bacteria, there is
a marked rise in the HMS activity, concomitant with enhanced motility of these cells
on glass.
I would like to ask Dr. Boren whether he feels there is little or no movement of
macrophages on the alveolar wall under any circumstance?
DR. BOREN: What I am picturing is that the transport of carbon particles to
macrophages may be similar to the transport of bacteria. A point of terminology we
need to clear up is the differences between alveolar macrophage and type B cells. The
cell which phagocytizes carbon is largely the Type B cell. This cell would function as
sort of an intermediate stage with anything that is brought to it. Subsequent events
might be killing of an agent, death of the cell, or transformation of the cell into a
macrophage. I feel that there is a continuing sequence in which the Type B cell be-
comes the alveolar macrophage. Macklin pointed out a number of years ago that
macrophages, if one defines them as "free-living" cells, were a function of the degree
of lung collapse at the time of fixation. I wonder if the techniques we use in which we
allow lungs to collapse as we wash them out may not encourage the assembly of a
large number of Type B cells, rather than just alveolar macrophages.
DR. KILBURN: This is one of the questions we have tried to answer by culturing
lung in Rose chambers. When you put a small slice of rabbit lung in a Rose chamber,
these Type B cells as identified by phase microscopy, over a period of up to three or
four days detach from the alveolar wall and become free-living on cellophane or glass.
This implies a continuum of alveolar cellular development and activity.
I am not certain, from looking at Dr. Boren's elegant pictures, whether that alveolar
cell migrated out to engulf the carbon particle and returned to its place in the wall,
or whether it remained fixed and ingested the carbon. It got the carbon, but by what
process is completely unsettled.
DR. CARRINGTON: I wonder if we can't draw a lesson from some of the com-
ments and the papers that have been given in the last two hours.
Dr. Green, for example, has shown a variety of factors which can influence the
bactericidal activity of the alveolar cells, and Dr. Forsyth has mentioned the prob-
lems of one agent activating another. Dr. Braude has commented on the difficulty of
demonstrating bacterial infections in some instances which we might call subtle.
I think the response we have to make to all of this is in part what Dr. Green has
done-to study very carefully the various factors in the controls as well as in the
experimental animal. I think just keeping paired litter mates or paired batches of
animals, exposing one to a variety of circumstances and holding one back in the
colony and after 18 months comparing the two, is simply not adequate to rule out
the possibility of an effect from one of these other factors. With careful studies, some
of these other factors can be included or excluded in a given situation; but simply
"holding a set of controls" is totally inadequate.
435